# Resmed (RMD): value investors who own it | moatshark

1 value investor held Resmed in their Q3 2026 13F, led by Giverny Capital. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Giverny Capital | 2.5% | $75.5m | Added +69% | 4 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-07 | Farrell Michael J. | Chairman and CEO | Sold | 4991 | $1.1m |
| 2026-09-08 | Farrell Michael J. | Chairman and CEO | Sold | 4991 | $1.1m |
| 2026-09-02 | FARRELL PETER C | Director | Sold | 970 | $228k |
| 2026-08-07 | Farrell Michael J. | Chairman and CEO | Sold | 4991 | $1.0m |
| 2026-08-05 | FARRELL PETER C | Director | Sold | 8000 | $1.8m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/rmd). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.